Auvelity ER 45-105 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FYRCL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,258
Award facts
- Contract value 100% obligated
- $16,257.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Auvelity ER 45-105 mg tablets (60-count units) with a ceiling value of $16,257.60. This is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) vehicle—specifically the DLA Troop Support Medical SPE2DX prime vendor contract valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems and maintains an extensive portfolio of medical product deliveries through the Defense Logistics Agency's Medical Supply Chain.
Auvelity is a combination antidepressant medication used in the treatment of major depressive disorder. This delivery order represents one of numerous pharmaceutical procurements under the DLA's broader pharmaceutical support strategy for military healthcare programs worldwide. AmerisourceBergen's designation as a prime vendor under the SPE2DX contract enables it to supply a comprehensive range of medications, including specialty drugs, brand-name and generic pharmaceuticals, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The ultimate completion date for this delivery order is scheduled for September 18, 2025.
Quick answers
Who was awarded contract SPE2DB25FYRCL?
SPE2DB25FYRCL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FYRCL worth?
The government has obligated $16,258 on SPE2DB25FYRCL.
Is contract SPE2DB25FYRCL an order under another contract?
Yes. SPE2DB25FYRCL is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYRCL competed?
The extent of competition for SPE2DB25FYRCL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award